Gritstone Bio Stock (NASDAQ: GRTS) stock price, news, charts, stock research, profile.
Open | $0.850 |
Close | $0.785 |
Volume / Avg. | 4.060M / 2.908M |
Day Range | 0.782 - 0.871 |
52 Wk Range | 0.672 - 3.330 |
Market Cap | $85.705M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 12.23% |
Days to Cover | 1.78 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Gritstone Bio (NASDAQ: GRTS) through any online brokerage.
Other companies in Gritstone Bio’s space includes: Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), Curis (NASDAQ:CRIS), Armata Pharmaceuticals (AMEX:ARMP) and Barinthus Biotherapeutics (NASDAQ:BRNS).
The latest price target for Gritstone Bio (NASDAQ: GRTS) was reported by JMP Securities on Tuesday, April 2, 2024. The analyst firm set a price target for 5.00 expecting GRTS to rise to within 12 months (a possible 525.00% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Gritstone Bio (NASDAQ: GRTS) is $0.8 last updated May 10, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Gritstone Bio.
Gritstone Bio’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Gritstone Bio.
Gritstone Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.